PCAS: Quarterly Financial Information As of September 30, 2013

Longjumeau, November 6, 2013

(in thousands of euros) 2012 published (including SBS) 2012 restated  (without SBS) 2013 % change
First Quarter 42 728 41 809 43 033 + 2.9%
including Pharmaceutical Synthesis 25 454 25 454 26 677 + 4.8%
including Fine Speciality Chemicals 17 274 16 355 16 356 0.0%
Second Quarter 46 633 45 697 46 011 + 0.7%
including Pharmaceutical Synthesis 29 910 29 910 31 400 + 5.0%
including Fine Speciality Chemicals 16 723 15 787 14 611 - 7.4%
Third Quarter 38 355 37 689 37 897 + 0.6%
including Pharmaceutical Synthesis 23 298 23 298 23 784 + 2.1%
including Fine Specialty Chemicals 15 057 14 391 14 113 - 1.9%
Total as of 30 September 127 716 125 195 126 941 + 1.4%
including Pharmaceutical Synthesis 78 662 78 662 81 861 + 4.1%
including Fine Speciality Chemicals 49 054 46 533 45 080 - 3.1%

As a reminder, the sale of SBS was finalized on March 20, 2013. SBS has been presented on a specific "Net result after tax of activities destined to be sold" line on December 31, 2012.

Consolidated revenue for the PCAS Group is up 1.4% at September 30, 2013 compared to the same period for the previous year.

Pharmaceutical Synthesis
Pharmaceutical Synthesis activities over the first nine months of 2013 are up 4.1% compared to 2012.

Fine Specialty Chemicals
There was a drop in Fine Specialty Chemicals activities at September 30, 2013 compared to September 30, 2012 (-3.1%), this segment having been affected by a marked slow-down in New Technologies activities, while Performance Chemicals and Fragrances, Flavors, Cosmetics activities continued to grow over the same period.

Business in the last quarter of 2013 is expected to be down compared to the last quarter of 2012, affected by customers caution, both for Pharmaceutical Synthesis and Fine Specialty Chemicals activities.

Overall, 2013 is likely to close with a turnover lower than that recorded in 2012.

About PCAS:

Founded in 1962, PCAS is an international fine and specialty chemicals group that shares an ambition for excellence with its customers, which primarily include market-leading international groups. PCAS designs and delivers the best industrial solutions for its customers' specific expectations. These various expectations all share a common demand for safety, quality, competitiveness, innovation and sustainability. PCAS also develops ranges of proprietary products based on intellectual property.

PCAS_Q3_2013:
http://hugin.info/143512/R/1741122/584872.pdf


This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.

Source: PCAS via Thomson Reuters ONE
HUG#1741122